Afoxolaner is an isoxazoline-class ectoparasiticide commonly utilized in veterinary medicine for the treatment and prevention of flea and tick infestations in dogs and cats. By acting as an antagonist… Read more
Afoxolaner is an isoxazoline-class ectoparasiticide commonly utilized in veterinary medicine for the treatment and prevention of flea and tick infestations in dogs and cats. By acting as an antagonist at the insect and acarine gamma-aminobutyric acid (GABA)-gated chloride channels, this compound effectively disrupts the parasite's central nervous system. In pharmaceutical laboratories, high-quality reference standards of this drug and its related derivatives are essential for rigorous quality control and method development. These substances, including stable isotope labelled compounds like Afoxolaner-d6, serve as critical internal standards in mass spectrometry and liquid chromatography to ensure precise impurity profiling and accurate quantification of active pharmaceutical ingredients during stability testing and routine batch analysis. Analytical professionals rely on these well-characterized materials to validate bioanalytical methods and maintain strict compliance with regulatory safety standards.